000			01990 a2200601 4500
005			20250514020909.0
264		0	_c20020122
008			200201s 0 0 eng d
022			_a0887-6924
024	7		_a10.1038/sj.leu.2402302 _2doi
040			_aNLM _beng _cNLM
100	1		_aLadetto, M
245	0	0	_aConcurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma. _h[electronic resource]
260			_bLeukemia _cDec 2001
300			_a1941-9 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Murine-Derived
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aFeasibility Studies
650	0	4	_aFemale
650	0	4	_aHematopoietic Stem Cell Transplantation
650	0	4	_aHumans
650	0	4	_aImmunotherapy
650	0	4	_aLymphoma, Non-Hodgkin _xcomplications
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm, Residual _xdiagnosis
650	0	4	_aPolymerase Chain Reaction
650	0	4	_aRituximab
650	0	4	_aSalvage Therapy
650	0	4	_aTransplantation, Autologous
650	0	4	_aTreatment Outcome
700	1		_aZallio, F
700	1		_aVallet, S
700	1		_aRicca, I
700	1		_aCuttica, A
700	1		_aCaracciolo, D
700	1		_aCorradini, P
700	1		_aAstolfi, M
700	1		_aSametti, S
700	1		_aVolpato, F
700	1		_aBondesan, P
700	1		_aVitolo, U
700	1		_aBoccadoro, M
700	1		_aPileri, A
700	1		_aGianni, A M
700	1		_aTarella, C
773	0		_tLeukemia _gvol. 15 _gno. 12 _gp. 1941-9
856	4	0	_uhttps://doi.org/10.1038/sj.leu.2402302 _zAvailable from publisher's website
999			_c11666130 _d11666130